All Parkinson’s articles

  • shutterstock_1659535552 (1)
    Article

    Year in review: EPR’s top stories of 2023

    2023-12-18T10:00:11Z

    EPR wraps up the year with a selection of top stories from 2023, highlighting key trends and topics such as environmental monitoring (EM), quality (QA/QC), manufacturing, regulation and clinical development.

  • drugs to watch 2023
    News

    Potential blockbuster drugs to watch in 2023

    2023-01-10T11:54:22Z

    Lecanemab for Alzheimer's and the first potential gene therapy primed for US launch for haemophilia A are two potential blockbuster Drugs to Watch™, says a 2023 report.